<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21983920</PMID><DateCompleted><Year>2012</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1435-4373</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>6</Issue><PubDate><Year>2012</Year><Month>Jun</Month></PubDate></JournalIssue><Title>European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology</Title><ISOAbbreviation>Eur J Clin Microbiol Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Reemerging of enterovirus 71 in Taiwan: the age impact on disease severity.</ArticleTitle><Pagination><StartPage>1219</StartPage><EndPage>1224</EndPage><MedlinePgn>1219-24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10096-011-1432-6</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) infection commonly strike children under the age of 3 years, with an occasionally unfavorable outcome in children. This study was designed to explore the relationship between age and the severity of complications, which may associate with antibody-dependent enhancement (ADE) in EV71. All EV71-infected patients during the outbreak of 2008 were recruited. In total, 134 patients were enrolled and categorized into two age groups, 0-12 months (n = 18) and &gt;12 months (n = 116). Pulmonary edema/hemorrhage more commonly occur in patients younger than 12 months. No difference in the occurrence of herpangina/hand-foot-and-mouth disease (HFMD), uncomplicated brainstem encephalitis (BE), or autonomic nervous system (ANS) dysregulation was noted between the two age groups. Patients with pulmonary edema/hemorrhage (11.9 &#xb1; 14.7 months) were younger than patients with herpangina/HFMD (35.8 &#xb1; 26.4 months) or ANS dysregulation (33.9 &#xb1; 20.9 months). Our findings are in agreement with the data regarding the outbreak in Taiwan, in which a decrease in age corresponded to an increase in disease severity with regard to central nervous system complications. A reduction of maternal antibodies to the subneutralizing level within 1 year of age may be associated with the ADE of the infection. This study could provide possible clinical significance with regard to ADE phenomena in young infants infected by EV71.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>S-M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, College of Medicine, National Cheng Kung University and Hospital, Tainan, Taiwan. pedwang@mail.ncku.edu.tw</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>T-S</ForeName><Initials>TS</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>H-C</ForeName><Initials>HC</Initials></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>H-Y</ForeName><Initials>HY</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>J-R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>C-C</ForeName><Initials>CC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Clin Microbiol Infect Dis</MedlineTA><NlmUniqueID>8804297</NlmUniqueID><ISSNLinking>0934-9723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021821" MajorTopicYN="N">Communicable Diseases, Emerging</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018792" MajorTopicYN="N">Encephalitis, Viral</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21983920</ArticleId><ArticleId IdType="doi">10.1007/s10096-011-1432-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Infect Dis. 2003 Aug 15;188(4):564-70</Citation><ArticleIdList><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2010 Aug;91(Pt 8):1949-1958</Citation><ArticleIdList><ArticleId IdType="pubmed">20375223</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2007 Oct 15;45(8):950-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17879907</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2007 Mar 1;44(5):646-56</Citation><ArticleIdList><ArticleId IdType="pubmed">17278054</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 1998 Aug 7;47(30):629-32</Citation><ArticleIdList><ArticleId IdType="pubmed">9704628</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1977 Jul 1;146(1):201-17</Citation><ArticleIdList><ArticleId IdType="pubmed">406347</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2000 Dec 5;278(1):86-94</Citation><ArticleIdList><ArticleId IdType="pubmed">11112484</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2009 Apr;15(4):581-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19331737</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr. 1998 Dec;133(6):795-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9842048</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 1999 Jul;29(1):184-90</Citation><ArticleIdList><ArticleId IdType="pubmed">10433583</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 2000 Jul;68(2):127-36</Citation><ArticleIdList><ArticleId IdType="pubmed">10958984</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2008 Oct 1;198(7):1002-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18710325</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2010 Oct;49(2):100-4</Citation><ArticleIdList><ArticleId IdType="pubmed">20719557</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2002 Jun;67(2):217-23</Citation><ArticleIdList><ArticleId IdType="pubmed">11992582</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust J Exp Biol Med Sci. 1964 Aug;42:465-82</Citation><ArticleIdList><ArticleId IdType="pubmed">14202187</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Vaccine Immunol. 2010 Oct;17(10):1517-23</Citation><ArticleIdList><ArticleId IdType="pubmed">20685937</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2000 Jun;17(1):23-30</Citation><ArticleIdList><ArticleId IdType="pubmed">10814935</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect. 1998 Nov;37(3):270-3</Citation><ArticleIdList><ArticleId IdType="pubmed">9892531</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1999 Sep 23;341(13):929-35</Citation><ArticleIdList><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2001 Jan 15;32(2):236-42</Citation><ArticleIdList><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2007 Aug;120(2):e244-52</Citation><ArticleIdList><ArticleId IdType="pubmed">17671037</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2006 Dec;118(6):e1785-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17116698</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2003 Jan;9(1):78-85</Citation><ArticleIdList><ArticleId IdType="pubmed">12533285</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2007 Nov;13(11):1733-41</Citation><ArticleIdList><ArticleId IdType="pubmed">18217559</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Med Virol. 2003 Nov-Dec;13(6):387-98</Citation><ArticleIdList><ArticleId IdType="pubmed">14625886</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2002 Sep;8(9):995-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12194783</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Cell Cardiol. 2002 Sep;34(9):1227-38</Citation><ArticleIdList><ArticleId IdType="pubmed">12392896</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1999 Sep 18;354(9183):987-91</Citation><ArticleIdList><ArticleId IdType="pubmed">10501361</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>